These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9921108)

  • 21. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
    Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
    Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
    Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
    Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher blood pressure in normoalbuminuric type 1 diabetic patients with a familial history of type 2 diabetes.
    Damci T; Osar Z; Ilkova H
    Diabetes Metab; 2002 Nov; 28(5):417-20. PubMed ID: 12461481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes mellitus--long time survival.
    Muller WA
    J Insur Med; 1998; 30(1):17-27. PubMed ID: 10186435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients.
    Ogawa S; Takeuchi K; Sugimura K; Sato C; Fukuda M; Lee R; Ito S; Sato T
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):461-4. PubMed ID: 10386239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.
    Halimi JM; Bonnet F; Lange C; Balkau B; Tichet J; Marre M;
    J Hypertens; 2008 Nov; 26(11):2198-206. PubMed ID: 18854761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus.
    Singh SK; Behre A; Singh MK
    J Assoc Physicians India; 2001 Apr; 49():439-41. PubMed ID: 11762615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes.
    Erdmann E
    Int J Cardiol; 2006 Feb; 107(2):147-53. PubMed ID: 15975669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes.
    Goldberg RB
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S682-91; discussion S692-6. PubMed ID: 11183421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16.
    Yokoyama H; Oishi M; Kawai K; Sone H;
    Diabet Med; 2008 Dec; 25(12):1426-32. PubMed ID: 19046241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microalbuminuria: a genetic link between diabetes and cardiovascular disease?
    Yudkin JS
    Ann Med; 1992 Dec; 24(6):517-22. PubMed ID: 1485948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of pancreatic β-cell function and insulin resistance with microalbuminuria in type 2 diabetes.
    Sun X; Xiao Y; Wang B; Lv WS; Liu Y; Chen Y; Wang YG
    Diabetes Res Clin Pract; 2015 Dec; 110(3):e22-6. PubMed ID: 26428073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Deidesheimer meeting: significance of classical and new risk factors in non-insulin-dependent diabetes mellitus.
    Yudkin JS
    J Diabetes Complications; 1997; 11(2):100-3. PubMed ID: 9101395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin treatment, NIDDM and atherosclerosis.
    Shumak SL
    CMAJ; 1991 Jul; 145(2):134. PubMed ID: 1860104
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical observations on allergic sensitivity to insulin.
    SNYDER HB
    South Med J; 1956 Jan; 49(1):70-3. PubMed ID: 13281691
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adverse reactions to insulin].
    Ayani Almagia I; Rodríguez Sasiain JM; Aguirre Gómez C
    An Med Interna; 1998 Jun; 15(6):342-3. PubMed ID: 9656525
    [No Abstract]   [Full Text] [Related]  

  • 39. [Is insulin atherogenic?].
    Viikari J
    Duodecim; 1981; 97(17):1379-82. PubMed ID: 7035128
    [No Abstract]   [Full Text] [Related]  

  • 40. Some chemical investigations on the structure of insulin.
    SANGER F
    Cold Spring Harb Symp Quant Biol; 1950; 14():153-60. PubMed ID: 15442908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.